structure of BCNIntermediateofCefcapene CAS 153012-37-4

BCNIntermediateofCefcapene CAS 153012-37-4

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

153012-37-4

Name

BCNIntermediateofCefcapene

Synonyms

(6S,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2E)-2-(2-{2-[(2-methyl-2-propanyl)oxy]-2-oxoethyl}-1,3-thiazol-4-yl)-2-pentenoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsäure –N-isopropyl-2-pro panamin (1:1) [German] [ACD/IUPAC Name]
(6S,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2E)-2-(2-{2-[(2-methyl-2-propanyl)oxy]-2-oxoethyl}-1,3-thiazol-4-yl)-2-pentenoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid – N-isopropyl- 2-propanamine (1:1) [ACD/IUPAC Name]
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2E)-2-[2-[2-(1,1-dimethylethoxy)-2-oxoethyl]-4-thiazolyl]-1-oxo-2-penten-1-yl]amino]-8-oxo-, (6S,7R)-, compd. with N-(1-methylethyl)-2-propanamine (1:1) [ACD/Index Name]
Acide (6S,7R)-3-[(carbamoyloxy)méthyl]-7-{[(2E)-2-(2-{2-[(2-méthyl-2-propanyl)oxy]-2-oxoéthyl}-1,3-thiazol-4-yl)-2-pentenoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ène-2-carboxylique – N-isoprop yl-2-propanamine (1:1) [French] [ACD/IUPAC Name]
153012-37-4 [RN]
Boc-Cefcapene.DIPA

Molecular Structure

structure of BCNIntermediateofCefcapene CAS 153012-37-4

structure of BCNIntermediateofCefcapene CAS 153012-37-4

SMILES

CC/C=C(\c1csc(n1)CC(=O)OC(C)(C)C)/C(=O)N[C@H]2[C@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O.CC(C)NC(C)C

StdInChI

InChI=1S/C23H28N4O8S2.C6H15N/c1-5-6-12(13-10-36-14(25-13)7-15(28)35-23(2,3)4)18(29)26-16-19(30)27-17(21(31)32)11(8-34-22(24)33)9-37-20(16)27;1-5(2)7-6(3)4/h6,10,16,20H,5,7-9H2,1-4H3,(H2,24,33)(H,26,29)(H,31,32);5-7H,1-4H3/b12-6+;/t16-,20+;/m1./s1

StdInChIKey

IAVQLVKSVQCUFH-DUVQPXSRSA-N

Molecular Formula

C29H43N5O8S2

Properties

Appearance

Yellowish crystalline powder

Specifications and Other Information of Our BCNIntermediateofCefcapene CAS 153012-37-4

Standard

Enterprise standard

Identification Methods

HPLC,IR

Purity

97% min

Loss on Drying

3.5% max

Absorbance(400nm, 1% MeOH)

0.2% max

Water(KF)

1.5% max

Storage

Under room temperature and away from light

Application

Used as the pharmaceutical Intermediates

Links

This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://caming.com/bcnintermediateofcefcapene-cas-153012-37-4/

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://watson-int.com/bcnintermediateofcefcapene-cas-153012-37-4/